1-6 of 6
Robert Schaub, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacokinetics and Pharmacodynamics after Subcutaneous Dosing of the iNKT Cell Depleting Antibody NKTT120

Robert Schaub, PhD, Abraham Thariath, PhD, Felix Scheuplein, PhD, Robert Mashal, MD
Journal: Blood
Blood (2015) 126 (23): 4575.
https://doi.org/10.1182/blood.V126.23.4575.4575
Published: 2015
Journal Articles

Adult Patients with Stable Sickle Cell Disease Prior to Treatment with the iNKT Cell Depleting Antibody NKTT120 Have Consistent and Elevated Numbers of Activated (CD69 + ) iNKT Cells Relative to Healthy Adult Volunteers

Rosemary Mazanet, MD PhD, Robert Schaub, PhD, Felix Scheuplein, PhD, Cheryl A. Eaton, BA, Robert Mashal, MD, Joshua J. Field, MD MS
Journal: Blood
Blood (2014) 124 (21): 4097.
https://doi.org/10.1182/blood.V124.21.4097.4097
Published: 2014
Journal Articles

Antibody Mediated Depletion of iNKT Cells Protects Against Hypoxia-Induced Pulmonary Injury in a Murine Model of Sickle Cell Disease

Hong Pei, PhD, Robert Schaub, PhD, Felix Scheuplein, PhD, Robert Mashal, MD, Joel Linden, PhD
Journal: Blood
Blood (2014) 124 (21): 2697.
https://doi.org/10.1182/blood.V124.21.2697.2697
Published: 2014
Journal Articles

Discovery and Characterization of An Anti-APC Aptamer for Use In Hemophilia

Patricia G.M. Wagner, Michael C. Schwartz, Kathleen E. McGinness, Ryan M. Genga, Jeffrey C. Kurz, PhD, Emily K. Waters, PhD, Robert Schaub, PhD
Journal: Blood
Blood (2010) 116 (21): 2222.
https://doi.org/10.1182/blood.V116.21.2222.2222
Published: 2010
Journal Articles

The Generation of An Aptamer Inhibitor of Murine Von Willebrand Factor (VWF) Mediated Platelet Aggregation

Melissa Woelfel, Simon De Meyer, PhD, Patricia Wagner, Kathleen E McGinness, PhD, Denisa D. Wagner, PhD, Robert Schaub, PhD
Journal: Blood
Blood (2010) 116 (21): 4312.
https://doi.org/10.1182/blood.V116.21.4312.4312
Published: 2010
Journal Articles

The Aptamer ARC1779 Potently and Specifically Inhibits the Excessive von Willebrand Factor (vWF) Activity and vWF-Mediated Ex Vivo Platelet Function of Patients with Thrombotic Thrombocytopenic Purpura (TTP).

Bernd Jilma, MD, Florian B. Mayr, MD, Paul Knoebl, MD, Alexander O. Spiel, MD, Patricia G. Merlino, Robert Schaub, PhD, James C. Gilbert, MD
Journal: Blood
Blood (2007) 110 (11): 279.
https://doi.org/10.1182/blood.V110.11.279.279
Published: 2007